Literature DB >> 2969254

Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction.

G A Oswald1, C C Smith, A P Delamothe, D J Betteridge, J S Yudkin.   

Abstract

Plasma concentration of beta thromboglobulin was used as an index of in vivo platelet activation in 36 patients after acute myocardial infarction. Twelve patients had diabetes, seven had pulmonary oedema or cardiogenic shock (pump failure) or both, and 17 had uncomplicated infarcts. On the first day of admission, concentrations of beta thromboglobulin were higher in the patients with diabetes and those with pump failure than in those with uncomplicated infarcts. Concentrations of beta thromboglobulin in the non-diabetic patients were studied by multiple regression analysis and were significantly associated with plasma concentrations of adrenaline, pump failure, and glucose but not with noradrenaline or infarct size. When all subjects were considered together, glucose, adrenaline, and pump failure were associated with the beta thromboglobulin concentration but diabetes was without significant effect. Hyperglycaemia and raised plasma adrenaline concentration after myocardial infarction may activate platelets, and this could contribute to poor outcome in such patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969254      PMCID: PMC1276873          DOI: 10.1136/hrt.59.6.663

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  46 in total

1.  Some observations on the preparation of platelet-rich plasma.

Authors:  B P Woods; A Dennehy; N Clarke
Journal:  Thromb Haemost       Date:  1976-11-30       Impact factor: 5.249

2.  A comparison between the plasma concentration of immunologically assayed platelet factor 4 and beta-thromboglobulin and the heparin thrombin clotting time.

Authors:  C A Ludlam; J R O'Brien; A E Bolton; M Etherington
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

3.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients.

Authors:  T Killip; J T Kimball
Journal:  Am J Cardiol       Date:  1967-10       Impact factor: 2.778

4.  Effects of adrenaline on human blood platelets.

Authors:  D C Mills; G C Roberts
Journal:  J Physiol       Date:  1967-11       Impact factor: 5.182

5.  Effect of diabetes on the course of acute myocardial infarction in Malta.

Authors:  J V Zammit Maempel
Journal:  Isr J Med Sci       Date:  1978-04

6.  Determinants of hospital admission and case fatality in diabetic patients with myocardial infarction.

Authors:  J S Yudkin; G A Oswald
Journal:  Diabetes Care       Date:  1988-04       Impact factor: 19.112

7.  Sequelae of concussion caused by minor head injuries.

Authors:  W H Rutherford
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321

8.  Plama-thromboglobulin concentrations in diabetes mellitus.

Authors:  A W Burrows; S I Chavin; T D Hockaday
Journal:  Lancet       Date:  1978-02-04       Impact factor: 79.321

9.  Plasma beta-thromboglobulin in diabetes mellitus.

Authors:  I W Campbell; J Dawes; D M Fraser; D S Pepper; B F Clarke; L J Duncan; J D Cash
Journal:  Diabetes       Date:  1977-12       Impact factor: 9.461

10.  Haemostatic variables associated with diabetes and its complications.

Authors:  J H Fuller; H Keen; R J Jarrett; T Omer; T W Meade; R Chakrabarti; W R North; Y Stirling
Journal:  Br Med J       Date:  1979-10-20
View more
  10 in total

1.  Scorpion envenomation among children: clinical manifestations and outcome (analysis of 685 cases).

Authors:  Mabrouk Bahloul; Imen Chabchoub; Anis Chaari; Kamilia Chtara; Hatem Kallel; Hassen Dammak; Hichem Ksibi; Hedi Chelly; Noureddine Rekik; Chokri Ben Hamida; Mounir Bouaziz
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

Review 2.  Homeostatic systems, biocybernetics, and autonomic neuroscience.

Authors:  David S Goldstein; Irwin J Kopin
Journal:  Auton Neurosci       Date:  2017-09-05       Impact factor: 3.145

3.  The effects of dopexamine, a new dopamine analogue, on platelet function in stress.

Authors:  D Wagaine-Twabwe; T J Hendra; C C Smith; J S Yudkin
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

4.  Admission glucose and left ventricular systolic function in non-diabetic patients with acute myocardial infarction.

Authors:  Joanna Gierach; Marcin Gierach; Iwona Świątkiewicz; Marek Woźnicki; Grzegorz Grześk; Adam Sukiennik; Marek Koziñski; Jacek Kubica
Journal:  Heart Vessels       Date:  2014-12-25       Impact factor: 2.037

Review 5.  Incidence, mechanisms and impact outcome of hyperglycaemia in severe scorpion-envenomed patients.

Authors:  Mabrouk Bahloul; Olfa Turki; Anis Chaari; Mounir Bouaziz
Journal:  Ther Adv Endocrinol Metab       Date:  2018-05-03       Impact factor: 3.565

6.  How to manage hyperglycemia in an acute coronary syndrome patient.

Authors:  David Vivas; Esther Bernardo; Julian Palacios-Rubio; Antonio Fernández-Ortiz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-02

7.  The threshold of admission glycemia as a predictor of adverse events in diabetic and non-diabetic patients with acute coronary syndrome.

Authors:  Taysir S Garadah; Salah Kassab; Qasim M Al-Shboul; Abdulhai Alawadi
Journal:  Clin Med Cardiol       Date:  2009-04-01

8.  Impact of Admission Glucose on Non-Diabetic Patients with ST-Segment Elevation Myocardial Infarction Treated with Percutaneous Coronary Intervention: A Meta-Analysis.

Authors:  Zhen-Xuan Hao; Yang Liu; Dan-Li Wang; Wen-Jie Han; Lei Wu; Heng-Liang Liu
Journal:  Acta Cardiol Sin       Date:  2016-03       Impact factor: 2.672

9.  On Arrival High Blood Glucose Level is Associated With Detrimental and Fatal Hospitalization Outcomes for Acute Coronary Syndrome.

Authors:  Anggoro B Hartopo; Budi Y Setianto; Putrika P R Gharini; Lucia K Dinarti
Journal:  Cardiol Res       Date:  2011-07-25

Review 10.  Impairment of Anti-Aggregatory Responses to Nitric Oxide and Prostacyclin: Mechanisms and Clinical Implications in Cardiovascular Disease.

Authors:  Yuliy Y Chirkov; Thanh H Nguyen; John D Horowitz
Journal:  Int J Mol Sci       Date:  2022-01-18       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.